Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

ClinicalTrials.gov ID: NCT05424276

Public ClinicalTrials.gov record NCT05424276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 3:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of IkT-148009 in Untreated Parkinson's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study investigates the safety and tolerability of drug IkT-148009 in untreated Parkinson's disease volunteers (30 to 80 years old). It also looks at the pharmacokinetics of IkT-148009 in the body and evaluates the effect of IkT-148009 on motor and non-motor features of the disease. This 12 week study is designed to be 3:1 randomized across 3 doses of IkT-148009 or placebo. Each participant will self-administer one of 3 doses or placebo of IkT-148009 once daily (QD) with food for 12 weeks. For more information, visit our website: www.the201trial.com

Study identification

NCT ID
NCT05424276
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ABLi Therapeutics, Inc.
Industry
Enrollment
137 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 15, 2023 (Actual)
Primary completion
Oct 25, 2024 (Actual)
Completion
Sep 13, 2025 (Actual)
Last update posted
Nov 19, 2025

2023 – 2025

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Neurology Scottsdale Arizona 85258 —
Neurology Little Rock Arkansas 72205 —
Neurology Reseda California 91335 —
Neurology Stamford Connecticut 06905 —
Neurologist Boca Raton Florida 33486 —
Neurology Miami Florida 33136 —
Neurology Naples Florida 34105 —
Neurology Tampa Florida 33609 —
Neurology Tampa Florida 33613 —
Neurology Foxborough Massachusetts 02035 —
Neurology South Dartmouth Massachusetts 02747 —
Neurology Farmington Hills Michigan 48334 —
Neurology Golden Valley Minnesota 55427 —
Neurology West Long Branch New Jersey 07764 —
Neurology Durham North Carolina 27705 —
Neurology Raleigh North Carolina 27607 —
Neurology Columbus Ohio 43221 —
Neurology Tulsa Oklahoma 74136 —
Neurology Portland Oregon 97239 —
Neurology Port Royal South Carolina 29935 —
Neurology Memphis Tennessee 38137 —
Neurology Nashville Tennessee 37232 —
Neurology Frisco Texas 75035 —
Neurology Houston Texas 77030 —
Neurology Round Rock Texas 78681 —
Neurology Kirkland Washington 98034 —
Neurology Madison Wisconsin 53705 —
Neurology Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05424276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2025 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05424276 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →